US Patent Issued to The University of North Carolina at Charlotte, OncoTAb on April 21 for "Tumor specific antibody conjugates and uses therefor" (North Carolina, California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,469, issued on April 21, was assigned to The University of North Carolina at Charlotte (Charlotte, N.C.) and OncoTAb Inc. (Marvin, N.C.).

"Tumor specific antibody conjugates and uses therefor" was invented by Pinku Mukherjee (Waxhaw, N.C.), Jordon Wang (San Carlos, Calif.), Kexin Huang (San Mateo, Calif.) and Yan HE (Hayward, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are antibodies, and fragments, derivatives, and nanoparticle conjugates thereof, particularly humanized derivatives thereof, which bind to tumor antigens. Also provided are nucleic acid molecules encoding chimeric antigen receptors (CARs) that bind to tumor antigen...